Vaccines are not big money makers
For the conspiracy quacks saying covid19 was created so a few people could make big bucks off of vaccines. You folks lurking need to try harder:
The global total of all vaccines for adults and children by all pharmaceutical companies that produce vaccines represents only 2% to 3% of a trillion-dollar, worldwide pharmaceutical industry.
Arent Vaccines Just Moneymakers for Pharmaceutical Companies?
A popular myth is that vaccines are simply a way for pharmaceutical companies to make money. That is false. Vaccines are not huge profit-makers for pharmaceutical companies. In fact, these companies make their profits by selling drugs that treat diseases. For example, sales of the Sovaldi drug for Hepatitis Cjust one treatment by one pharmaceutical company for one disease sold almost entirely in the United States exceeded more than $10 billion in one year.
In comparison, the global total sales of all vaccinesfor adults and children by all pharmaceutical companies that produce vaccineswas just $24 billion in one year. The $24 billion vaccine market seems large but represents only 2% to 3% of a trillion-dollar, worldwide pharmaceutical industry.
Another point of comparison is the global alternative medicine market. That market, which includes homeopathic remedies and various supplements, powders, and teas, is a $34 billion industry, even though only one-third of the treatments have been tested.
More: http://www.boostoregon.org/arent-vaccines-just-moneymakers-for-pharmaceutical-companies
Why Are Pharmaceutical Companies Gradually Abandoning Vaccines?
ABSTRACT
During the past fifty years, the number of pharmaceutical companies making vaccines has decreased dramatically, and those that still make vaccines have reduced resources to make new ones. Pharmaceutical companies are gradually abandoning vaccines because the research, development, testing, and manufacture of vaccines are expensive and because the market to sell vaccines is much smaller than the market for other drug products. Congressional action could assure both a steady supply of existing vaccines and the promise of vaccines for the future.
https://www.healthaffairs.org/doi/full/10.1377/hlthaff.24.3.622